SLRX icon

Salarius Pharmaceuticals
SLRX

Overview Fund Trends Analyst Outlook Journalist POV

3 hedge funds and large institutions have $13.4K invested in Salarius Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$12.6K

Top Sellers

1
-$4.59K
2
-$2.32K
3
-$10
4
BlackRock
BlackRock
New York
-$1
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$13K
2
$297
3
$20
4
$13
5
$2
6
$2
7
–
8
–